返回
The Lung Microbiome
DOI:10.4049/jimmunol.2300716.png)
摘要
En 中文
Although the lungs were once considered a sterile environment, advances in sequencing technology have revealed dynamic, low-biomass communities in the respiratory tract, even in health. Key features of these communities- composition, diversity, and burden-are consistently altered in lung disease, associate with host physiology and immunity, and can predict clinical outcomes. Although initial studies of the lung microbiome were descriptive, recent studies have leveraged advances in technology to identify metabolically active microbes and potential associations with their immunomodulatory by-products and lung disease. In this brief review, we discuss novel insights in airway disease and parenchymal lung disease, exploring host-microbiome- microbiome interactions in disease pathogenesis. We also discuss complex interactions between gut and oropharyngeal microbiota and lung immunobiology. Our advancing knowledge of the lung microbiome will provide disease targets in acute and chronic lung disease and may facilitate the development of new therapeutic strategies. The Journal of Immunology, , 2024, 212: 1269-1275.- 1275.
Keyword:
BACTERIAL-INFECTION
AIRWAY MICROBIOME
PULMONARY
PATHOGENESIS
PROGRESSION
IMMUNITY
DECLINE
DISEASE
UPDATE
COPD
期刊
IF:
3.4
论文数:
3.7W
被引数:
9.9W
机构
引用论文
Interleukin-6 Delays Neutrophil Apoptosis via a Mechanism Involving Platelet-Activating FactorInterleukin-6通过涉及血小板活化因子的机制延迟中性粒细胞凋亡
Lung Homeostasis: Influence of Age, Microbes, and the Immune System肺稳态: 年龄,微生物和免疫系统的影响
IMMUNITY
IF26.3
The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice
NATURE MEDICINE
IF50
Microbiota regulates immune defense against respiratory tract influenza A virus infection微生物群调节对呼吸道甲型流感病毒感染的免疫防御

